Table 2:
Characteristics | Patients evaluated, n | Patients affected, n (%) | OR | 95% CI | P value |
---|---|---|---|---|---|
Gender | |||||
Male | 1109 | 826 (74.50) | 0.217 | 0.162, 0.290 a | < 0.001 |
Female | 911 | 848 (93.10) | 4.612 | 3.453, 6.160 b | < 0.001 |
Age (years) | |||||
≤ 9 | 146 | 105 (71.92) | 0.044 | 0.015, 0.127 c | < 0.001 |
10–19 | 332 | 214 (64.46) | 0.031 | 0.011, 0.086 c | < 0.001 |
20–29 | 424 | 356 (83.96) | 0.090 | 0.033, 0.251 c | < 0.001 |
30–39 | 459 | 400 (87.15) | 0.012 | 0.042, 0.326 c | < 0.001 |
40–49 | 423 | 367 (86.76) | 0.113 | 0.040, 0.316 c | < 0.001 |
≥ 50 | 236 | 232 (98.31) | - | - | - |
Statistical analyses were done using Chi-square (X2) test with P < 0.001 indicating significance.
Comparison with female patients as reference.
Comparison with male patients as reference.
Comparison with age group of 50 years and above as reference.